Drug Database
Back to search

Netherlands· NL-936425f8abcd

Slinda 4 mg filmomhulde tabletten

A drospirenone product containing drospirenon, registered in Netherlands by Exeltis Healthcare S.L. The same ATC class is registered in 13 of our 19 countries.

ATC G03AC10

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedSlinda 4 mg filmomhulde tablettenATCG03AC10REGISTER NO.NL-936425f8abcdPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about drospirenonAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Drospirenone is registered in 13 of 19 countries.

Countries holding a registration under ATC G03AC10 (drospirenone), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose
Search drospirenone products by name

Drospirenone · ATC G03AC10

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
DROSPIRENON
Manufacturer
Exeltis Healthcare S.L
Country
Netherlands (NL)
ATC code
G03AC10
ATC class
Drospirenone
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    127386

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

172 interactions on record for drospirenone.

Graded by severity as the source publishes them — 27 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check drospirenone against other medicinesHow interaction checks work

Drospirenone · interactions on record

172 records

  • 27 severe
  • 143 moderate
  • 2 minor

Most severe, free to view

  • Tranexamic acidB02AA02severe
  • GriseofulvinD01AA08severe
  • GriseofulvinD01BA01severe
  • KetoconazoleH02CA03severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Drospirenone in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All drospirenone products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3fc664bf-2530-442f-a271-650f6e1c83cf
GET /v1/drugs/3fc664bf-2530-442f-a271-650f6e1c83cf?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h127386_smpc.pdf",
  "strength": null,
  "atc_label": "Drosperinone",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg127386",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "GLYCEROLTRIACETAAT (E 1518)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE GEEL (E 172)",
    "INDIGOKARMIJN ALUMINIUMLAK (E 132)",
    "LACTOSE 0-WATER",
    "LACTOSE 1-WATER",
    "MACROGOL 3350",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL",
    "POLYSORBAAT 80 (E 433)",
    "POLYVINYLALCOHOL, GEDEELTELIJK GEHYDROLYSEERD (E1203)",
    "POVIDON K 30 (E 1201)",
    "SILICIUMDIOXIDE (E 551)",
    "SILICIUMDIOXIDE (E 551)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "DROSPIRENON"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h127386.pdf",
  "authorised_at": "2021/03/17",
  "procedure_number": "SE/H/1893/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "127386",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about drospirenone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console